dr. tyna moore glp-1 I was recently joined by and Calley Means on The Doctor's Farmacy for a controversial discussion of agonists like Ozempic, weighing the pros and cons of these peptides The Truth About GLP-1s And

"GIP and GLP-1, the Two Incretin Hormones: Similarities and Differences"

A group of researchers, including oncologists and data scientists, from the University of Florida and Indiana University hypothesized that GLP-1s hold promise in oncology due to their ability to lower glucose, adiposity, insulin resistance, and systemic inflammation factors associated with cancer progression, according to a July 2025 paper published in JAMA

As more patients use glucagon-like peptide-1 (GLP-1) receptor agonists for weight loss and to manage their type 2 diabetes, reports of these drugs effects on hair loss have emerged, including a retrospective cohort study 2 and a disproportionality analysis 3 of the U.S

ACT 1: What Is Foundayo, and Why Is It Different

Avgerinos, K

Therefore, antidiabetic medication decreases blood sugar levels, reduces body weight through a reduction in appetite [94], and lowers glycated hemoglobin (HbA1c), all while having a low risk of causing hypoglycemia [104]